Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies. (8th March 2021)

• Record Type: Journal Article
• Authors: Ashraf, Ghulam Md; Ebada, Mahmoud Ahmed; Suhail, Mohd; Ali, Ashraf; Uddin, Md. Sahab; Bilgrami, Anwar L.; Perveen, Asma; Husain, Amjad; Tarique, Mohd; Hafeez, Abdul; Alexiou, Athanasios; Ahmad, Ausaf; Kumar, Rajnish; Banu, Naheed; Najda, Agnieszka; Sayed, Amany A.; Albadrani, Ghadeer M.; Abdel-Daim, Mohamed M.; Peluso, Ilaria; Barreto, George E.
• Other Names: Garcia-Rivas Gerardo Academic Editor.
• Is Part Of: Oxidative medicine and cellular longevity. Volume 2021(2021)
• Publication Date: 2021-03-08
• Subjects: Oxidative stress -- Periodicals; Cells -- Aging -- Periodicals; Cells -- Aging; Oxidative stress; Oxidative Stress -- Periodicals; Cell Aging -- Periodicals; Periodicals; 611.0181
• DOI: 10.1155/2021/4572471
• Languages: English
• ISSNs: 1942-0900

Abstract

Abstract : The brain is a sexually dimorphic organ that implies different functions and structures depending on sex. Current pharmacological approaches against different neurological diseases act distinctly in male and female brains. In all neurodegenerative diseases, including Alzheimer's disease (AD), sex-related outcomes regarding pathogenesis, prevalence, and response to treatments indicate that sex differences are important for precise diagnosis and therapeutic strategy. Pathogenesis of AD includes vascular dementia, and in most cases, this is accompanied by metabolic complications with similar features as those assembled in diabetes. This review discusses how AD-associated dementia and diabetes affect cognition in relation to sex difference, as both diseases share similar pathological mechanisms. We highlight potential protective strategies to mitigate amyloid-beta (A β ) pathogenesis, emphasizing how these drugs act in the male and female brains.